| Application no. and date | 18769793.3 (espacenet) (Federated) (European Patent Register), 20180820 | | Patent/reg. no. and date | DK/EP 3672571, 20211006 | | Publication date | 20200701 | | Priority no. and date | US 201762550007 P, 20170825, US 201862681720 P, 20180607, US 201862703022 P, 20180725 | | EP pub. no. and date |
EP 3672571 20200701 | | Effective date | | | Applicant/owner | Pfizer Inc., 235 East 42nd Street
New York, NY 10017, US | | Applicant ref. no. | V351315DK00 | | Inventor | HUSSEY, James Joseph, c/o Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ, GB,
BRIGHT, Andrew Gilbert, c/o Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/5377 (2006.01) , A61K 47/20 (2006.01) , A61K 47/40 (2006.01) , A61K 9/00 (2006.01) , A61K 9/19 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) | | Title | Farmaceutisk vandig formulering omfattende 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea | | Int. application no. | IB2018056281 | | Int. publication no. | WO2019038657 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
